Business Context and Reporting Period
Core Scientific, Inc. filed this Form 8-K on September 20, 2023, reporting entry into a Purchase and Sale Agreement dated September 14, 2023 with Celsius Mining LLC. Core Scientific and certain affiliates remain debtors-in-possession in Chapter 11 proceedings initiated on December 21, 2022. The company’s common stock and warrants trade on the OTC Pink Marketplace under CORZQ and CRZWQ.
Material Transaction and Key Financial Terms
| Item | Terms |
|---|---|
| Transaction | Sale of the Cedarvale Facility in Ward County, Texas, and related assets to Celsius, together with specified contract assignments and a limited license to use certain materials. |
| Total consideration | $45 million, subject to the conditions in the Purchase and Sale Agreement. |
| Cash component | $14 million. |
| Non-cash component | Full and final release, satisfaction, and expungement of Celsius claims against the Debtors related to the Celsius Contracts. |
| Excluded claims | Celsius claims arising under or related to the April 19, 2021 Secured Convertible Note Purchase Agreement remain outstanding and are not part of the settlement. |
Changes Versus the Prior Period
- The agreement resolves litigation and disputed pass-through tariff charges related to Celsius-hosted mining operations, which Celsius had refused to pay after filing for Chapter 11 in July 2022.
- The transaction would transfer the Cedarvale Facility and related assets to Celsius and release specified claims asserted by Core Scientific against Celsius.
- The filing does not provide comparative revenue, profit, cash flow, margin, debt, or liquidity figures.
Outlook, Conditions, and Risks
- Closing is subject to, among other matters, approval by both the Core Bankruptcy Court and the Celsius Bankruptcy Court.
- The Purchase and Sale Agreement provides termination and specific-performance remedies if either party fails to perform its obligations and the failure is not cured within the specified period or by the Outside Date.
- The settlement may improve estate liquidity through the $14 million cash payment and reduce disputed claims, but the filing does not state the timing of payment, the Outside Date, or the accounting impact of the transaction.
- Core Scientific continues to operate under Chapter 11 jurisdiction, creating ongoing bankruptcy execution, approval, and creditor-recovery risks.
- The filing does not provide management guidance or broader operating outlook commentary.
Important Facts to Verify
- Whether both bankruptcy courts approve the settlement and whether the transaction closes.
- The timing and receipt of the $14 million cash payment.
- The final treatment and valuation of the released Celsius claims and the Cedarvale assets.
- The status and amount of Celsius claims related to the Secured Convertible Note Purchase Agreement, which remain outstanding.
- The effect of the transaction on Core Scientific’s Chapter 11 plan, creditor recoveries, asset base, and future mining capacity.